OpenAlex
PricingAboutJobs
Log inGet started
Work

Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.

PubMed

Year: 1996
Type: article
Source: PubMed
Authors: H Zia, T Hida, S Jakowlew, M Birrer, Y Gozes, J C Reubi, M Fridkin, I Gozes, T W Moody
Institutions: National Institutes of Health, National Cancer Institute
Language: English

Topic: Neuropeptides and Animal Physiology
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: vasoactive intestinal peptide, VIP receptor antagonist, breast cancer, pituitary adenylate cyclase-activating polypeptide, cAMP signaling, c-fos, c-Myc, tumor growth inhibition, xenografts, MDA-MB-231 cells, receptor binding
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1500051268
FWCI: 2.127
Cites: 17
Cited by: 107
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms